Preliminary Program

The Protein Society Annual Symposium 2027 (PS41)
July 9 - 12, 2027 | San Francisco, California | Hilton San Francisco Union Square

The 41st Annual Symposium is comprised of 12 scientific sessions and eight award speakers totaling over 100 invited and contributed talks speakers. Our program committee, chaired by Karen Allen, Boston University, and Chuck Sanders, Vanderbilt University, has assembled a program that spans the broad range of protein science, combining critical underpinnings of the field, the latest developments and a vision into the future with career development and technical workshops as well as ample networking opportunities. This year’s symposium continues our commitment to open participation, with each session featuring contributed talks and speakers from across a broad range of topics, and will feature the inaugural recipient of the Martin Karplus Award, established in 2026. 

Elliott
Sean Elliott | Boston University
CO2 Transforming Enzymes
Booker
Squire Booker | University of Pennsylvania
Pletneva
Kate Pletneva | Dartmouth College
Heme Enzymes and Electron Carriers in Energy Pathways
Chang, Michelle
Michelle Chang | Princeton University
New Metalloenzyme Discovery
Vahe Bandarian
Vahe Bandarian | University of Utah
New Enzymatic Transformations and Natural Products
Whitty
Adrian Whitty | Boston University
Protein Conformational Change in Gating Drug-target Binding
Tonge
Peter Tonge | Stony Brook University
Conformational Change and Slow Binding Inhibitors
Spies
Maria Spies | University of Iowa
Machines Supporting DNA Integrity
Finau
Isaac Finau | California Institute of Technology
O'Toole
Katherine O'Toole | New England Biolabs
Schlebach
Jonathan Schlebach | Purdue University
Pharmacological Chaperones and Cystic Fibrosis
Kosuri
Sriram Kosuri | Octant
Targeting Rhodopsin With pharm-chaps to Treat Retinitis Pigmentosa
Skretas
Georgios Skretas | Biomedical Sciences Research Center “Alexander Fleming”
New Methods for Developing Folding Correctors
Slavoff
Sarah Slavoff | Yale University
Dark Matter of the Human Genome
Saghatelian
Alan Saghatelian | Salk Institute for Biological Studies
Peptides That Control Cellular Processes
Anne-Ruxandra Carvunis
Anne-Ruxandra Carvunis | ETH Zürich
MS Identifications of Human Proteins From Proteomics and Peptidomics Datasets
Barna
Maria Barna | Stanford University
Hetoerogeneity of Ribosomes From Person to Person
Korostelev
Andrei Korostelev | U Mass Chan Medical School
In Extracto cryo-EM
Karbstein
Katrin Karbstin | Vanderbilt University
Ribosome Homeostasis
Benner
Steven Benner | Foundation For Applied Molecular Evolution
Clemons
Bil Clemons | California Institute of Technology
Fleming
Karen Fleming | Johns Hopkins University
Chaperoning of Outer Membrane Proteins
Van Horn
Wade Van Horn | Arizona State University
How Small Molecules Modulate TRP Channels Through Different Mechanisms
Shoichet
Brian Shoichet | University of California San Francisco
Drug Screening
Madani
Ali Madani | Profluent
Frontier Protein Language Models and Functional Protein Generation
Marks
Debbie Marks | Harvard University
Song
Jiangning Song | Monash University
Informatics in Therapeutic Discovery
Kalafatovic
Daniela Kalafatovic | University of Rijeka, Croatia
AI for Peptide Design
Bhardwaj
Gaurav Bhardwaj | University of Washington
AI-enabled Design of Membrane-permeable Peptide Therapeutics
Hoecker
Birte Hoecker | University of Bayreuth
From Protein Scaffolds to Catalysts: Principles for De Novo Enzyme Design
Chica
Roberto Chica | University of Ottawa
Designing Enzyme Dynamics for New Catalytic Functions
Deane
Charlotte Deane | Oxford University